STEPHEN STAHL

CARLSBAD, CA NPI 1710144167

Browse related groups: CA ITI, Inc. All categories

General Payments — all program years on this page

$3,132,103.78

Category: General Payments
Program years: PY2018–2024
Record count: 501
As of (CMS publication): 2026-01-23

Latest program year (PY2024): $47,979.85 across 39 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated

The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of payment	Amount	Records
Consulting Fee	$35,190.00	10
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$5,530.00	1
Travel and Lodging	$4,260.78	16
Honoraria	$2,280.00	2
Food and Beverage	$669.89	8
Education	$49.18	2

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entity	Amount	Records
ITI, Inc.	$28,435.96	24
E.R. Squibb & Sons, L.L.C.	$14,184.71	8
Alkermes, Inc.	$3,030.00	3
Supernus Pharmaceuticals, Inc.	$2,280.00	2
Otsuka Pharmaceutical Development & Commercialization, Inc.	$49.18	2

By program year

Program year	Amount	Records
2018	$1,751,687.34	121
2019	$544,141.31	133
2020	$543,331.50	65
2021	$91,329.76	35
2022	$46,858.13	24
2023	$106,775.89	84
2024	$47,979.85	39

Records — PY2024 (39)

Record ID	Paying entity	Amount	Date	Nature of payment	Dispute status	Published	Source
1101342923	E.R. Squibb & Sons, L.L.C.	$148.53	07/02/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1101342939	E.R. Squibb & Sons, L.L.C.	$1,049.55	08/12/2024	Travel and Lodging	Undisputed	01/23/2026	View at CMS
1101342949	E.R. Squibb & Sons, L.L.C.	$264.00	08/12/2024	Travel and Lodging	Undisputed	01/23/2026	View at CMS
1101342951	E.R. Squibb & Sons, L.L.C.	$4,977.00	11/14/2024	Consulting Fee	Undisputed	01/23/2026	View at CMS
1101342959	E.R. Squibb & Sons, L.L.C.	$125.00	11/27/2024	Travel and Lodging	Undisputed	01/23/2026	View at CMS
1101342971	E.R. Squibb & Sons, L.L.C.	$707.63	10/21/2024	Travel and Lodging	Undisputed	01/23/2026	View at CMS
1101342975	E.R. Squibb & Sons, L.L.C.	$1,383.00	11/18/2024	Consulting Fee	Undisputed	01/23/2026	View at CMS
1101342979	E.R. Squibb & Sons, L.L.C.	$5,530.00	12/09/2024	Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	Undisputed	01/23/2026	View at CMS
1118839925	Otsuka Pharmaceutical Development & Commercialization, Inc.	$24.59	07/03/2024	Education	Undisputed	01/23/2026	View at CMS
1118839927	Otsuka Pharmaceutical Development & Commercialization, Inc.	$24.59	07/03/2024	Education	Undisputed	01/23/2026	View at CMS
1120602322	Alkermes, Inc.	$505.00	06/24/2024	Consulting Fee	Undisputed	01/23/2026	View at CMS
1120602324	Alkermes, Inc.	$505.00	10/07/2024	Consulting Fee	Undisputed	01/23/2026	View at CMS
1120602326	Alkermes, Inc.	$2,020.00	12/16/2024	Consulting Fee	Undisputed	01/23/2026	View at CMS
1143326378	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$121.00	02/19/2024	Travel and Lodging	Undisputed	01/23/2026	View at CMS
1143326381	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$121.00	02/19/2024	Travel and Lodging	Undisputed	01/23/2026	View at CMS
1143326385	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$156.59	02/19/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1143326389	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$121.00	02/20/2024	Travel and Lodging	Undisputed	01/23/2026	View at CMS
1143326393	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$121.00	02/20/2024	Travel and Lodging	Undisputed	01/23/2026	View at CMS
1143326397	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$17.01	02/20/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1143326401	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$27.52	02/20/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1143326404	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$6,600.00	02/20/2024	Consulting Fee	Undisputed	01/23/2026	View at CMS
1143326408	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$121.00	04/18/2024	Travel and Lodging	Undisputed	01/23/2026	View at CMS
1143326412	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$121.00	04/18/2024	Travel and Lodging	Undisputed	01/23/2026	View at CMS
1143326416	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$13.88	04/18/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1143326420	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$35.94	04/18/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1143326424	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$4,800.00	04/18/2024	Consulting Fee	Undisputed	01/23/2026	View at CMS
1143326428	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$124.59	06/05/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1143326431	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$5,400.00	06/05/2024	Consulting Fee	Undisputed	01/23/2026	View at CMS
1143326435	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$200.00	06/05/2024	Travel and Lodging	Undisputed	01/23/2026	View at CMS
1143326438	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$125.00	06/05/2024	Travel and Lodging	Undisputed	01/23/2026	View at CMS
1143326442	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$262.38	06/05/2024	Travel and Lodging	Undisputed	01/23/2026	View at CMS
1143326446	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$125.00	06/05/2024	Travel and Lodging	Undisputed	01/23/2026	View at CMS
1143326450	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$338.11	06/27/2024	Travel and Lodging	Undisputed	01/23/2026	View at CMS
1143326453	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$338.11	06/27/2024	Travel and Lodging	Undisputed	01/23/2026	View at CMS
1143326457	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$4,800.00	06/27/2024	Consulting Fee	Undisputed	01/23/2026	View at CMS
1143326461	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$145.83	06/27/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1143326465	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$4,200.00	07/22/2024	Consulting Fee	Undisputed	01/23/2026	View at CMS
1147891778	Supernus Pharmaceuticals, Inc.	$1,140.00	08/22/2024	Honoraria	Undisputed	01/23/2026	View at CMS
1147891780	Supernus Pharmaceuticals, Inc.	$1,140.00	09/25/2024	Honoraria	Undisputed	01/23/2026	View at CMS

Provenance & corrections

Dataset: CMS Open Payments — General Payments
Source: CMS Open Payments dataset (bulk file)
Publisher of source data: Centers for Medicare & Medicaid Services
Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.